Showing 1 - 5 results of 5 for search 'Annukka Pasanen', query time: 0.01s Refine Results
  1. 1
    HER2 amplification and HER2 low expression in endometrial carcinoma: prevalence across molecular, histological and clinicopathological risk groups

    HER2 amplification and HER2 low expression in endometrial carcinoma: prevalence across molecular, histological and clinicopathological risk groups by Karoliina Aro, Mikko Loukovaara, Ralf Bützow, Annukka Pasanen

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Chromatin state origins of uterine leiomyoma

    Chromatin state origins of uterine leiomyoma by Maritta Räisänen, Eevi Kaasinen, Maija Jäntti, Aurora Taira, Emma Siili, Ralf Bützow, Oskari Heikinheimo, Annukka Pasanen, Auli Karhu, FinnGen, Davide G. Berta, Niko Välimäki, Lauri A. Aaltonen

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Activation of FGFR genes by genetic and epigenetic alterations in uterine leiomyomas

    Activation of FGFR genes by genetic and epigenetic alterations in uterine leiomyomas by Vilja Jokinen, Aurora Taira, Åsa Kolterud, Isa Ahlgren, Kimmo Palin, Riku Katainen, Maritta Räisänen, Eevi Kaasinen, Sini Ilves, Anniina Raitila, Helena Kopp Kallner, Emma Siili, Ralf Bützow, Oskari Heikinheimo, Annukka Pasanen, Auli Karhu, Niko Välimäki, Lauri A. Aaltonen

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Structural features of somatic and germline retrotransposition events in humans

    Structural features of somatic and germline retrotransposition events in humans by Päivi Nummi, Tatiana Cajuso, Tuukka Norri, Aurora Taira, Heli Kuisma, Niko Välimäki, Anna Lepistö, Laura Renkonen-Sinisalo, Selja Koskensalo, Toni T. Seppälä, Ari Ristimäki, Kyösti Tahkola, Anne Mattila, Jan Böhm, Jukka-Pekka Mecklin, Emma Siili, Annukka Pasanen, Oskari Heikinheimo, Ralf Bützow, Auli Karhu, Kathleen H. Burns, Kimmo Palin, Lauri A. Aaltonen

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial

    The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial by Matthew Stephen Block, James Hugo Armstrong Clubb, Johanna Mäenpää, Santeri Pakola, Dafne Carolina Alves Quixabeira, Tatiana Kudling, Elise Jirovec, Lyna Haybout, Mirte van der Heijden, Sanae Zahraoui, Susanna Grönberg-Vähä-Koskela, Sini Raatikainen, Victor Arias, Saru Basnet, Nea Ojala, Teijo Pellinen, Annabrita Hemmes, Katja Välimäki, Annukka Pasanen, Tuomo Alanko, Daniel Adamo, Susan Ramadan, Jorma Sormunen, Juha Kononen, Julia Wanda Cohen, Michael Jon Chisamore, John Goldfinch, Suvi Sorsa, Riikka Havunen, Claudia Kistler, Aino Kalervo, Víctor Cervera-Carrascon, João Manuel dos Santos, Akseli Hemminki

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: